Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China - PubMed (original) (raw)

Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China

J F Wang et al. Infect Immun. 1992 Dec.

Erratum in

Infect Immun 1994 Dec;62(12):5706

Abstract

Representative strains of serogroup A Neisseria meningitidis were chosen from all major meningitis epidemics worldwide since 1960 and subjected to analysis for the electrophoretic variation of 15 cytoplasmic allozymes and four outer membrane proteins. The 290 strains defined 84 unique electrophoretic types which were classified in nine subgroups. Tests with monoclonal antibodies specific for conserved pilin epitopes showed that the class I, IIa, and IIb epitopes were uniform within the subgroups. Similarly, the subgroups were uniform for expression of different variable regions of class 1 outer membrane protein, with a few minor exceptions. Many of the bacteria tested were isolated in the People's Republic of China, and the epidemiology of Chinese epidemics of meningococcal meningitis is described. The analysis approaches a global description of epidemic meningitis caused by serogroup A meningococci in the past 30 years.

PubMed Disclaimer

Cited by

Distributed genotyping and clustering of Neisseria strains reveal continual emergence of epidemic meningococcus over a century.
Zhong L, Zhang M, Sun L, Yang Y, Wang B, Yang H, Shen Q, Xia Y, Cui J, Hang H, Ren Y, Pang B, Deng X, Zhan Y, Li H, Zhou Z. Zhong L, et al. Nat Commun. 2023 Nov 24;14(1):7706. doi: 10.1038/s41467-023-43528-0. Nat Commun. 2023. PMID: 38001084 Free PMC article.
Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
Zhu FC, Hu YM, Li YN, Shu JD, Oster P. Zhu FC, et al. Hum Vaccin Immunother. 2021 Mar 4;17(3):919-926. doi: 10.1080/21645515.2020.1801077. Epub 2020 Dec 3. Hum Vaccin Immunother. 2021. PMID: 33270487 Free PMC article. Clinical Trial.
Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies.
Sherman AC, Stephens DS. Sherman AC, et al. Expert Rev Vaccines. 2020 May;19(5):455-463. doi: 10.1080/14760584.2020.1760097. Epub 2020 Apr 29. Expert Rev Vaccines. 2020. PMID: 32321332 Free PMC article. Review.
Genomic characterization of novel Neisseria species.
Diallo K, MacLennan J, Harrison OB, Msefula C, Sow SO, Daugla DM, Johnson E, Trotter C, MacLennan CA, Parkhill J, Borrow R, Greenwood BM, Maiden MCJ. Diallo K, et al. Sci Rep. 2019 Sep 24;9(1):13742. doi: 10.1038/s41598-019-50203-2. Sci Rep. 2019. PMID: 31551478 Free PMC article.
The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment.
Maiden MCJ. Maiden MCJ. Front Immunol. 2019 Jan 15;9:3151. doi: 10.3389/fimmu.2018.03151. eCollection 2018. Front Immunol. 2019. PMID: 30697213 Free PMC article. Review.

References

1. N Engl J Med. 1972 Jul 6;287(1):5-9 - PubMed
1. Rev Infect Dis. 1982 Jan-Feb;4(1):159-72 - PubMed
1. J Infect Dis. 1992 Jan;165(1):53-68 - PubMed
1. Lancet. 1991 Aug 31;338(8766):554-7 - PubMed
1. Lancet. 1991 Nov 2;338(8775):1143-4 - PubMed

Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China - PubMed (original) (raw)